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Introduction: Brugada Syndrome (BrS) is a disorder associated with an 
increased risk of sudden cardiac death and speci¿ c electrocardiographic (ECG) 
features. Loss- of- function mutations in SCN5A underlie BrS in ~25% of cases. 
Other genes account for only less than 1%. Thus the genetic basis of the BrS 
remains unknown in the majority of cases. Furthermore linkage analysis failed to 
identify new genes, likely due to the low penetrance of the disease and perhaps 
also due to the lack of speci¿ city of the Na+ channel blockers used to unmask the 
BrS ECG- pattern. To make progress in the genetic basis of the BrS we applied a 
new strategy: exome sequencing on 3 highly characterized Dutch pedigrees with 
BrS that were previously tested negative for mutations in SCN5A.
Methods: We carried out exome sequencing (ES) in 2 or 3 individuals from 
each pedigree. In addition to presenting with BrS- ECG at baseline, the 2 or 3 
individuals were selected based on their genetic distance. ES was carried out on 
Illumina sequencers using Agilent SureSelect 50Mb capturing. Different genome 
analysis algorithms were used (GATK, samtools, SOAPsnp and dindel) for 
variant calling. The Knime4Bio pipeline was used to manage and ¿ lter variants. 
Variants were ¿ ltered against dbSNP132 as well as the emerging ES databases 
(GoNL, NHLBI ES Project and 800 exomes from the Sanger Institute).
Used analysis strategy: We compared exomes from 2 or 3 affected indivi-
duals per family to identify shared variants. Variants identi¿ ed in this way (15 
to 40 per family) are validated by PCR/Sanger sequencing and tested for co- 
segregation with the disease in the respective pedigrees.
Results and conclusions: Genes (<5 per family) that we identi¿ ed using 
these strategy in the 3 pedigrees are presently being tested for mutations in a 
large set of probands with BrS.
In our comparison of the different variant calling algorithms we noticed 
that among the variants found only by the GATK algorithm, only ~10% could 
be validated.
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Brugada syndrome (BrS) is characterized by an ST- segment elevation in the 
right precordial leads unrelated to ischemic or structural heart disease. It shows 
familial segregation and is associated with malignant arrhythmias leading to 
sudden death. Mutations in SCN5A, the α- subunit of the cardiac Na+ channel 
Nav1.5, are linked to BrS. We identi¿ ed a family affected by BrS (5 patients), 
conduction defects (3 patients) and/or short QT syndrome (SQTS, 4 patients). 
The proband, affected by BrS and conduction defects is carrier of a SCN5A 
variant leading to the substitution Q1695X. In this family, this mutation strictly 
segregated with the conduction defects. However, the mutation is absent in 2 
BrS patients. The absence of cosegregation with BrS suggests the existence of 
other molecular bases. Recent studies have shown that BrS and SQTS may be 
caused by mutations in the genes CACNA1C and CACNB2b coding for α1c 
and β2b subunits of the cardiac calcium channel Cav1.2. This channel is res-
ponsible for the Ca2+ inÀ ux (ICa, L) essential for excitation- contraction coupling 
in cardiomyocytes. Sequencing CACNA1C revealed a missense variant leading 
to the substitution N300D, in 6 patients including the proband. Five of them 
are affected by BrS. Furthermore, SQTS and BrS were observed in the patients 
carrying only Cav1.2- N300D. In order to further study this correlation, we inves-
tigated the effects of N300D substitution on Cav1.2 function using whole- cell 
patch clamp on COS- 7 cells expressing α1c, β2b and α2δ1b human subunits. 
Cav1.2- N300D reduced ICa, L (- 0.68±0.38pA/pF, n=18) when compared with 
Cav1.2 WT (- 5.51±1.7pA/pF, n=18, p<0.001). Western blot experiments showed 
a reduced global and cell- surface expression of Cav1.2- N300D. We are currently 
studying the protein localization using confocal microscopy in order to charac-
terize the mechanisms leading to this loss of function. Action potential model-
ling will be used to investigate the normalized QT interval in double carriers.
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Andersen- Tawil syndrome (ATS) is an uncommon form of long QT syn-
drome (LQT7) linked to mutations in the KCNJ2 gene. Currently, few is 
known on the long term arrhythmic prognosis of this disease.
Methods: We have conducted a retrospective multicenter study in 9 French 
hospitals. Patients were recruited only if they were carrier of a KCNJ2 mutation.
Results: Thirty patients (female n=17) were included with a mean follow-
 up of 6.6 years. The mean age at diagnosis was 30+/- 19 years. 
Twelve patients (40%) experienced syncope and one patient was resusci-
tated from a cardiac arrest before inclusion. The mean QTc interval was 441+/- 
56ms and the QTUc 608+/- 92ms. All patients had a normal ejection fraction 
(EF). Holter recording found 12 260 ventricular premature beats (VPBs) per 
day on average, 19 patients had episodes of bigeminy and 4 patients had poly-
morphic PVC. 19 patients had non- sustained polymorphic ventricular tachy-
cardia (VT), and 6 sustained polymorphic VT. Only 1 patient presented with 
torsade de pointes. 
23 patients were treated with B- blocker (n=23), amiodarone (n=2), À e-
cainid (n=2), acetazolamide (n=4). 5 patients had a radiofrequency ablation. 
An implantable cardiac de¿ brillator (ICD) was implanted in 3 patients. During 
follow- up, none of the patients died, 4 experienced syncope under treatment 
and 1 patient had a non- fatal cardiac arrest.
Conclusion: Despite a severe clinical presentation with a very high rate 
of ventricular arrhythmia, the arrhythmic prognosis of the Andersen- Tawil 
patients seems to be relatively good under treatment.
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Risk strati¿ cation in Brugada syndrome (BS) is problematic for asympto-
matic or mildly symptomatic patients, and the role of programmed ventricular 
stimulation (PVS) in risk strati¿ cation has been controversially discussed. 
Therefore, we conducted a meta- analysis on the prognostic role of PVS in BS 
according to clinical presentation.
Methods: Only publications in English with at least 15 patients and a 
follow- up period with a record of arrhythmic events were considered. Studies 
with redundant data were excluded. Research until January 2012 documented 
13 studies with 2098 patients who underwent PVS. Patients were divided into 
two groups: one group surviving a sudden cardiac arrest (SCA) (n=203, 10%) 
and one group with other patients (with a history of syncope or asymptomatic, 
n=1895, 90%).
Results: In 1099 patients (52%), sustained ventricular tachyarrhyth-
mias (VT) or ventricular ¿ brillation (VF) was inducible. During follow- up 
(35±40 months), VT/VF occurred in 181 patients. The odds ratio for VT/
VF during follow- up in relation to a positive PVS was not signi¿ cant for 
patients with SCA (OR=1.38, 95% CI 0.33- 5.80, p=0.66). By contrast, induc-
tion of VT/VF was associated with an increased risk of cardiac events in 
patients patients without a history of SCA (syncope or asymptomatic patients, 
OR=2.64, 95% CI 1.06- 6.62, p=0.04).
Conclusion: The role of PVS for risk strati¿ cation in patients with BS and 
a history of SCA is questionable. By contrast, PVS seems useful in asympto-
matic or poorly symptomatic patients with BS since the inducibility of sus-
tained VT/VF may identify an increased risk of arrhythmic events during 
follow- up.
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Early Repolarization (ER) has been reported to increase the risk of 
arrhythmic death. However it is a common ¿ nding in the general population 
(5%). We sought to investigate the outcome of patients with syncope asso-
ciated with ER. 
Methods: All patients hospitalized for syncope and presenting J wave 
elevation 01mV in at least 2 inferior (II, III, aVF) and/or lateral leads 
(V4- V6, I, aVL) from 17 centers have been included. ECGs were analyzed 
independently by 2 electrophysiologists before inclusion in a prospective 
registry. Referring physicians managed the patients according to their local 
practice. 
Results: Fifty- three patients (47 males, 35±14yo) have been included. J 
wave elevation was present in inferior 23 (43%), lateral 8 (15%) or infero- 
lateral leads 22 (42%) displaying a mean J wave elevation of 0.19±0.09mV 
including 29 patients (55%) with a J point elevation 0.2mV. Thirteen (25%) 
had a family history of sudden cardiac death (SCD). Twenty- eight (53%) 
patients received an implantable loop recorder (ILR) and 7 (13%) an ICD 
after initial evaluation because of syncope characteristics associated to family 
history of SCD (n=4) or spontaneous polymorphic VT recorded (n=3) during 
in hospital monitoring.
During a median follow- up of 8 (3- 16) months, 50 remained asymptomatic 
and 3 had recurrent syncope without ventricular arrhythmia on ILR in 1 and 
typical neurocardiogenic in the other 2. Two patients had non sustained poly-
morphic ventricular tachycardia recorded on ILR log during sleep (¿ gure) and 
further received an ICD. 
Conclusion: J wave elevation in the setting of syncope may help iden-
tifying patient at high risk of ventricular arrhythmia.
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Brugada syndrome (BS) is an inherited autosomal dominant disease cha-
racterized by a typical ECG pattern showing a ST segment elevation and right 
bundle branch bloc aspect. In 20 to 25% of patients, loss- of- function muta-
tions can be found in alpha subunit of the predominant cardiac sodium channel 
Nav1.5. Some of these mutations affect the traf¿ cking of Nav1.5 protein, 
which is then retained in intracellular compartments.
The aim of this study was to mimic patient’s heterozygosity by co- 
expressing the traf¿ cking defective mutant R1432G and wild- type (WT) chan-
nels in HEK293T cells. The impact of this mutant on the function, protein 
synthesis, and cellular localization of WT channels was investigated combi-
ning electrophysiology, imaging and biochemical approaches.
Co- expressing R1432G with WT channels caused a signi¿ cant 2- fold 
decrease in current density compared with cells expressing Nav1.5/WT alone. 
When R1432G and WT channels were co- expressed, no signi¿ cant effect on 
proteasome- dependent degradation level of Nav1.5 channels was detected. 
Nevertheless, cell surface biotinylation experiments revealed, from a protein- 
equivalent amount of total lysates, a reduction in membrane channel expres-
sion when WT and mutant forms were co- transfected.
Our data clearly indicate a negative dominance of R1432G mutants on 
WT proteins. This effect would be associated with an alteration in membrane 
traf¿ cking of WT channels. As a consequence, these results strongly suggest 
that the reduction of expected Nav1.5 membrane current in BS patients is 
underestimated.
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Early repolarization (ER) has been implicated in a syndrome of ventricular 
¿ brillation in patients without organic heart disease. ER with horizontal/des-
cending ST- segment recently was reported to identify patients at increased 
arrhythmic risk.
In this study, we evaluated prevalence and ECG characteristics of early 
repolarization in a population of healthy amateur endurance runners.
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Methods: Retrospectively, we analyzed resting 12 leads ECGs of 447 par-
ticipants (310, 69% males; age 47±9 years) of four editions of local marathon. 
Early repolarization was de¿ ned as € 0.1mV QRS- ST junction (J- point) ele-
vation with terminal QRS slurring or notching in at least 2 contiguous inferior 
and/or lateral leads. In leads with ER we analyzed ST- segment 100ms after 
the J point and classi¿ ed ST- segment as ascending/upsloping if >0.1mV above 
baseline and horizontal/descending if  0.1mV.
Results: Mean heart rate, PR interval, QRS duration, Sokolow- Lyon index and 
QTc interval were: 67±37bpm, 161±21ms, 95±12ms, 28±5mV and 403±34ms, 
respectively. Thirty (6%) athletes had ¿ rst degree AV block, 3% RBBB and one 
athlete LBBB. Electrical LV hypertrophy was found in 52 runners (11%) and pro-
longed QTc interval in 17 (4%).Early repolarization was present in 28 runners 
(6.3%) affecting inferior leads in 21 (75%), high lateral leads in 4 (14%) and 
low lateral leads in 3 runners (11%). Mean J wave amplitude was 0.17±0.7mV. 
A notched J wave was observed in 7 athletes (25%), slurred in 21 (75%).A J wave 
with horizontal/descending ST- segments was present in 9 athletes (32%) and J 
wave with ascending/upsloping in 19 (68%).Other classical ECGs characteristics 
in athletes with ER were as follow; heart rate: 65±11bpm, PR: 160±22ms, QRS 
duration: 91±12ms, Sokolow- Lyon index: 27±5 and QTc interval: 412±19ms.
Conclusion: Prevalence of early repolarisation in this population of healthy 
middle aged amateur athletes was 6.3%. ER was mainly found in inferior 
leads with predominant ST segment being ascending/upsloping variant.
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Background: Early repolarization (ER), de¿ ned as an elevation of the 
J- point of more than 0.1mV in two adjacent leads other than V1- V3, is a 
common ECG particularity found in approximatively 5% of the healthy popu-
lation. However, several recent studies have shown the existence of a link 
between ER and sudden cardiac death. At present, there is no way to predict 
the potential malignancy of an early repolarization. Therefore, we looked for 
the presence of late ventricular potentials (LVP) in ER to assess the risk of 
sudden cardiac death. 
Method:  Three independent observers prospectively analyzed 12- lead 
ECG in a population of 1538 soldiers. We randomly constitued an ER and 
a control group, each consisting of 70 persons matched on age and ethnic 
origins. Subjects with incomplete/complete bundle branch block, or disor-
ders of repolarization (other than ER) were excluded. Looking for LVP was 
achieved if the background noise was <0.5V. LVP were considered present 
if there was at least two criteria among: QRSf>120ms, LAS40>40ms, or 
RMS40<20V.
Results: LVP were signi¿ cantly more common in the ER group than in 
control (respectively 30% versus 4%, p=0.03). 5 subjects were excluded 
because of an excessive background noise. The lenght of QRSf and LAS were 
signi¿ cantly higher in the ER- group (respectively: QRSf: 118±3 vs 114±1.8 
p=0.04; LAS40:38±3 vs 31±1.6, p=0.001).
Discussion: In this study, because of the frequency of LVP in ER, High 
ampli¿ ed ECG may have no interest to predict the malignancy of 
ER. Furthermore, physiologically, late ventricular potentials correspond to 
delayed depolarization, and not to early repolarization. Therefore, the excess 
of LVP in ER has no use in routine clinical practice, and could be an explained 
cause of false positive.
